BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

750 related articles for article (PubMed ID: 2062331)

  • 1. Improved survival in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Clinical experience in 108 patients.
    Bell WR; Braine HG; Ness PM; Kickler TS
    N Engl J Med; 1991 Aug; 325(6):398-403. PubMed ID: 2062331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment outcomes in patients with adult thrombotic thrombocytopenic purpura-hemolytic uremic syndrome.
    Hayward CP; Sutton DM; Carter WH; Campbell ED; Scott JG; Francombe WH; Shumak KH; Baker MA
    Arch Intern Med; 1994 May; 154(9):982-7. PubMed ID: 8179455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Microangiopathic hemolytic anemias. Clinical pattern, therapy and clinical course in 14 patients with thrombotic thrombocytopenic purpura and hemolytic uremic syndrome].
    Krause M; Fehr J; Gmür J; Keusch G; Frick P; Oelz O
    Schweiz Med Wochenschr; 1986 Nov; 116(48):1666-74. PubMed ID: 3798063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathophysiology and management of thrombotic microangiopathies.
    Ruggenenti P; Remuzzi G
    J Nephrol; 1998; 11(6):300-10. PubMed ID: 10048496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombotic thrombocytopenic purpura and related disorders.
    Ruggenenti P; Remuzzi G
    Hematol Oncol Clin North Am; 1990 Feb; 4(1):219-41. PubMed ID: 2107174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical analysis on thrombotic thrombocytopenic purpura and hemolytic uremic syndrome, with plasma level of cytokine].
    Wada H; Saitoh M; Tamaki S; Masuya M; Morita K; Tabata M; Tanigawa M; Kageyama S; Tsuzi K; Ohta C
    Rinsho Ketsueki; 1990 Sep; 31(9):1537-43. PubMed ID: 2246829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The renal manifestations and outcome of thrombotic thrombocytopenic purpura/hemolytic uremic syndrome in adults.
    Conlon PJ; Howell DN; Macik G; Kovalik EC; Smith SR
    Nephrol Dial Transplant; 1995; 10(7):1189-93. PubMed ID: 7478122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: pathophysiology and management.
    Myers L
    Nephrol Nurs J; 2002 Apr; 29(2):171-80; quiz 181-2. PubMed ID: 11997952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pregnancy outcomes after recovery from thrombotic thrombocytopenic purpura-hemolytic uremic syndrome.
    Vesely SK; Li X; McMinn JR; Terrell DR; George JN
    Transfusion; 2004 Aug; 44(8):1149-58. PubMed ID: 15265118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of response and relapse in a cohort of adults with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: a single-institution experience.
    Tuncer HH; Oster RA; Huang ST; Marques MB
    Transfusion; 2007 Jan; 47(1):107-14. PubMed ID: 17207238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathological characteristics and outcome of Chinese patients with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: a 9-year retrospective study.
    Zhang W; Shi H; Ren H; Shen PY; Pan XX; Li X; Chen YX; Xu YW; Chen XN; Zhu P; Chen N
    Nephron Clin Pract; 2009; 112(3):c177-83. PubMed ID: 19439988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma manipulation in hemolytic uremic syndrome and thrombotic thrombocytopenic purpura.
    Remuzzi G; Ruggenenti P
    Ann Med Interne (Paris); 1992; 143 Suppl 1():19-26. PubMed ID: 1300882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of thrombotic microangiopathies].
    Debourdeau P; Zammit C; Souleau B; Védrine L; Farge-Bancel D
    Ann Med Interne (Paris); 1999 Sep; 150(5):374-87. PubMed ID: 10544747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathophysiology and treatment of thrombotic thrombocytopenic purpura/hemolytic uremic syndrome (TTP/HUS).
    Kakishita E
    Int J Hematol; 2000 Jun; 71(4):320-7. PubMed ID: 10905050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombotic microangiopathy: current knowledge and outcomes with plasma exchange.
    Clark WF
    Semin Dial; 2012; 25(2):214-9. PubMed ID: 22309967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Thrombotic microangiopathy in adults].
    Barrientos GJ; Michelangelo H
    Medicina (B Aires); 2006; 66(4):289-95. PubMed ID: 16977962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treating TTP/HUS with plasma exchange: a single centre's 25-year experience.
    Forzley BR; Sontrop JM; Macnab JJ; Chen S; Clark WF
    Br J Haematol; 2008 Oct; 143(1):100-6. PubMed ID: 18691172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequency and significance of schistocytes in TTP/HUS patients at the discontinuation of plasma exchange therapy.
    Egan JA; Hay SN; Brecher ME
    J Clin Apher; 2004; 19(4):165-7. PubMed ID: 15597353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic plasma exchange does not appear to be effective in the management of thrombotic thrombocytopenic purpura/hemolytic uremic syndrome following bone marrow transplantation.
    Sarode R; McFarland JG; Flomenberg N; Casper JT; Cohen EP; Drobyski WR; Ash RC; Horowitz MM; Camitta B; Lawton C
    Bone Marrow Transplant; 1995 Aug; 16(2):271-5. PubMed ID: 7581147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Thrombotic thrombocytopenic purpura and hemolytic uremic syndrome (TTP/HUS). Description of a series of 35 patients].
    Martínez Francés A; Pereira A; Ordinas A
    Med Clin (Barc); 1997 Jun; 109(2):49-52. PubMed ID: 9280801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.